One Week With: two thousand seventeen Nissan 370Z, Automobile Magazine

One Week With: two thousand seventeen Nissan 370Z

E ight years from its production debut in 2009, the Nissan 370Z soldiers on. In this industry, we treat model years like dog years, making Nissan`s rear-drive sports car fairly the senior citizen. Observing as the Z`s sales figures aren`t what they used to be, and the future of the vaunted Z-car line is uncertain, we spent a week with a base-model 370Z to see how the coupe holds up toward the tail-end of 2016. Continue reading One Week With: two thousand seventeen Nissan 370Z, Automobile Magazine

One Dead and twenty two Injured as Car Rams Into Pedestrians in Times Square – The Fresh York Times

One Dead and twenty two Injured as Car Rams Into Pedestrians in Times Square

One person was killed and at least twenty two were injured when a car struck pedestrians in Fresh York’s Times Square. The driver of the car has been taken into custody.

By MALACHY BROWNE, AINARA TIEFENTHÄLER and NEETI UPADHYE on Publish Date May Legitimate, 2017. Continue reading One Dead and twenty two Injured as Car Rams Into Pedestrians in Times Square – The Fresh York Times

OEM News Releases, Automotive World

Automotive World Information and networking for auto industry professionals

September Five, two thousand seventeen

Fresh from its launch in June, the updated Mazda CX-3 has taken to the stunning roads of Norway for the latest of Mazda UK’s Epic Drive media events. Over the course of a week, the CX-3s took in some of Scandinavia’s finest roads, highlighting both the enhanced refinement and the . Continue reading OEM News Releases, Automotive World

November Auto Sales: GM, Nissan, VW Rise as FCA Tumbles, CMO Strategy

November Auto Sales: GM, Nissan, VW Rise as FCA Tumbles

By David Phillips. Published on December 01, two thousand sixteen .

Most Popular

Ford, Honda, Nissan, Toyota and General Motors posted U.S. sales increases in November as a rise in incentive spending helped put the industry back on a winning track after three straight monthly declines. Continue reading November Auto Sales: GM, Nissan, VW Rise as FCA Tumbles, CMO Strategy

Novartis-Backed Leukemia Probe Shows 82% Remission with CAR T Cell Therapy

Novartis-Backed Leukemia Investigate Shows 82% Remission with CAR T Cell Therapy

A very innovative, personalized cell-based treatment for a high-risk form of the most common childhood cancer resumes to stir through clinical trials. Pediatric oncologists from Children’s Hospital of Philadelphia (CHOP) reported fresh results using T cell immunotherapy against relapsed or refractory acute lymphoblastic leukemia (ALL). Continue reading Novartis-Backed Leukemia Probe Shows 82% Remission with CAR T Cell Therapy

Novartis’ CAR-T therapy was the very first approved in U

Novartis’ CAR-T therapy was the very first approved in U.S. — here’s how to invest in the space

Published: Sept Five, two thousand seventeen 6:58 a.m. ET

Companies that provide services and solutions to cell therapy companies will become invaluable, says Janney analyst Knight

EmmaCourt

On Wednesday, the very first of a fresh type of cancer-fighting cell therapy called CAR-T was approved in the U.S.: Novartis AG’s Kymriah, intended to treat youthful people with acute lymphoblastic leukemia. Continue reading Novartis’ CAR-T therapy was the very first approved in U